APC mutation correlated with poor response of immunotherapy in colon cancer
Abstract Objective APC (adenomatous polyposis coli) gene mutation is a central initialization in colon cancer tumorigenesis. However, the connection between APC gene mutation and immunotherapy efficacy for colon cancer remains unknown. This study aimed to explore the impact of APC mutation on immuno...
Main Authors: | Bing Li, Guoliang Zhang, Xuejie Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-023-02725-3 |
Similar Items
-
Review of Immunogenomics and the Role of Tumor Mutational Burden as a Biomarker for Immunotherapy Response
by: Javier Ros, et al.
Published: (2019-10-01) -
Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy
by: Xiushen Li, et al.
Published: (2021-11-01) -
BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers
by: Huiping Shi, et al.
Published: (2024-01-01) -
Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer
by: Hao Chen, et al.
Published: (2020-01-01) -
A Case of Sporadic Multiple Colonic Polyps in a Young Woman
by: Seung Ho Sin, et al.
Published: (2023-01-01)